The Incidence and Predictors of Early- and Mid-Term Clinically Relevant Neurological Events after Transcatheter Aortic Valve Replacement in Real-World Patients

Journal of the American College of Cardiology

Volumn 66, Issue 3, 2015, Pages 209-217

  Bosmans, Johan ^a   Bleiziffer, Sabine ^b   Gerckens, Ulrich ^c   Wenaweser, Peter ^d   Brecker, Stephen ^e   Tamburino, Corrado ^f   Linke, Axel ^g  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Gemeinschaftskrankenhaus   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

^e ST GEORGE S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF CATANIA   (Italy)

^g UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

aortic stenosis; self expanding transcatheter aortic valve; stroke; transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; HEPARIN;

ACUTE KIDNEY FAILURE; AGED; AORTA VALVE PROSTHESIS; AORTA VALVE STENOSIS; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; COLOMBIA; CORONARY ARTERY BYPASS SURGERY; EUROPE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; ISRAEL; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MEDICAL SPECIALIST; MULTICENTER STUDY (TOPIC); PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; SEX DIFFERENCE; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; VASCULAR DISEASE; VERY ELDERLY; ADVERSE EFFECTS; AORTA VALVE; AORTIC VALVE STENOSIS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DEVICES; HEART VALVE PROSTHESIS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN MEIER METHOD; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; STROKE; TIME;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIER ESTIMATE; MALE; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84937412577     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.05.025     Document Type: Article

References (13)

1. B. Iung, A. Cachier, G. Baron, and et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26 2005 2714 2720
2. S.K. Kodali, M.R. Williams, C.R. Smith, and et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 2012 1686 1695
3. R.R. Makkar, G.P. Fontana, H. Jilaihawi, and et al. Transcatheter aortic valve replacement for inoperable severe aortic stenosis N Engl J Med 366 2012 1696 1704
4. D.H. Adams, J.J. Popma, M.J. Reardon, and et al. Transcatheter aortic valve replacement with a self-expanding prosthesis N Engl J Med 370 2014 1790 1798
5. A. Linke, P. Wenaweser, U. Gerckens, and et al. Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study Eur Heart J 35 2014 2672 2684
6. D.L. Walters, G.C. Mang, D.G. Platts, and et al. Characterization of neurological injury in transcatheter aortic valve implantation. How clear is the picture? Circulation 129 2014 504 515
7. M.B. Leon, C.R. Smith, M. Mack, and et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
8. C.R. Smith, M.B. Leon, M.J. Mack, and et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
9. M.B. Leon, N. Piazza, E. Nikolsky, and et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium J Am Coll Cardiol 57 2011 253 269
10. D.C. Miller, E.H. Blackstone, M.J. Mack, and et al. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial J Thorac Cardiovasc Surg 143 2012 832 843
11. Windecker S. Two-year outcomes from the SOURCE XT post approval registry. Paper presented at: Annual Meeting of EuroPCR; May 22, 2014; Paris, France.
12. H. Omran, H. Schmidt, M. Hackenbroch, and et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study Lancet 361 2003 1241 1246
13. I.J. Amat-Santos, J. Rodés-Cabau, M. Urena, and et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation J Am Coll Cardiol 59 2012 178 188